Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC LY2801653 1206799-15-6 100mg
SDP

Supplier:  Apexbio Technology LLC A3573100

Encompass_Preferred

LY2801653 (CAS 1206799-15-6) is an orally bioavailable small molecule inhibitor targeting the c-MET receptor tyrosine kinase with an IC50 of 2 nM c-MET also known as hepatocyte growth factor receptor (HGFR) mediates key cellular processes including proliferation survival and motility its dysregulation has been associated with tumor progression and metastasis LY2801653 acts as an ATP-competitive inhibitor of c-MET phosphorylation In vitro it fully inhibits HGF-induced cell scattering in DU-145 cells at concentrations from 0 01 to 10 M and shows greater antiproliferative effects in MET-expressing cell lines In vivo LY2801653 reduces apoptosis and angiogenesis in xenograft models supporting its utility in cancer research

Catalog No. 50-000-93739


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.